ArticleIn vivo (Athens, Greece)
NeuroD2 Modulates Hippocampal Neuronal Organization and Axon Guidance During Aging.
Article in In vivo (Athens, Greece). The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
BACKGROUND/
aimBiological aging refers to the progressive deterioration of an organism's functions due to accumulated cellular and molecular damage. NeuroD2, a critical transcription factor, plays a crucial role in neuronal development and synaptic maturation. This study investigates the role of NeuroD2 in hippocampal neuron organization, focusing on hilar mossy cells during aging, and employs bioinformatics to identify NeuroD2 targets linked to cellular aging. MATERIALS AND
methodsWe used 21 adult C57Bl/6 mice, categorized into three age groups: young (2 months), old (12 months), and very old (24 months). Mice were administered BrdU intraperitoneally for three consecutive days, 10 days before euthanasia. The brains were harvested and analyzed using immunofluorescence, Western blotting, and quantitative real-time PCR to evaluate NeuroD2 expression and associated signaling pathways in hippocampal tissue. Additionally, bioinformatics analysis was performed using two open-access datasets (ProteomeXchange Consortium, Dataset identifier: PXD043352; Gene Expression Omnibus, GEO: GSE67539) and to explore potential interactions between NeuroD2 targets and biological aging components.
resultsOur results revealed that NeuroD2 expression changed significantly with age and correlated with AKT signaling. Moreover, we identified a potential link between NeuroD2 activity and the AKT pathway, indicating NeuroD2's role in mitigating aging-related stress. Bioinformatics analysis identified 513 down-regulated and 638 up-regulated proteins, with NeuroD2 targets involved in axonal projection showing increased expression in older mice. Contrary to expectations, pathway enrichment analysis highlighted axon guidance molecules rather than oxidative stress markers.
conclusionThis study underscores NeuroD2's critical role in preserving hippocampal integrity and reveals molecular mechanisms underlying age-related neuronal changes. Our findings provide insights into the role of NeuroD2 in regulating key pathways during healthy aging, potentially mitigating the impacts of aging.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.